ProMIS Neurosciences issues Chairman's update memorandum and white paper on Alzheimer
ProMIS Neurosciences issues Chairman's update memorandum and white paper on Alzheimer's disease
ProMIS Neurosciences issues Chairman'''s update memorandum and white paper on Alzheimer'''s disease News story cameo's Biogen's TPD-43 research for Amyotrophic Lateral Sclerosis and shows molecule, dropped for futility, may need further consideration: aducanumab. |
All times are GMT -5. The time now is 07:34 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.